Sun Pharmaceutical Industries has seen strong momentum after announcing a major international acquisition, strengthening its global footprint.
The deal is expected to enhance the company’s product portfolio and expand its presence in key markets such as the US. This strategic move reflects the company’s focus on long-term growth through global expansion.
Analysts believe the acquisition could boost revenue and improve margins over time, making the company a key player in the pharmaceutical sector.
